Here below are the four submissions for which KEI was the lead author to the UN Secretary General’s High Level Panel (HLP) on Access to Medicine.
- “The Need for Global Negotiations on Agreements to Fund R&D within the Context of a Progressive De-linking of R&D Costs from Product Prices [1]“. Supported by 12 organizations; 1 individual; 3 Members of European Parliament.
- “Increasing the Transparency of Markets for Drugs, Vaccines, Diagnostics and other Medical Technologies” [2]. Supported by 17 organizations; 2 individuals; 3 Members of European Parliament.
- “The Role of R&D Subsidies for Clinical Trials in Progressive Delinkage of R&D Costs from Product Prices [3]“
- “Trade Agreements and the Supply of Public Goods [4]“
February 28th, 2016
February 28th, 2016
February 28th, 2016
February 28th, 2016